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Abstract Purpose: Changes in
electrolyte homeostasis are important
causes of acid–base disorders. While
the effects of chloride are well stud-
ied, only little is known of the
potential contributions of sodium to
metabolic acid–base state. Thus, we
investigated the effects of intensive
care unit (ICU)-acquired hypernatre-
mia on acid–base state.
Methods: We included critically ill
patients who developed hypernatre-
mia, defined as a serum sodium
concentration exceeding 149 mmol/
L, after ICU admission in this retro-
spective study. Data on electrolyte
and acid–base state in all included
patients were gathered in order to
analyze the effects of hypernatremia
on metabolic acid–base state by use
of the physical–chemical approach.
Results: A total of 51 patients were
included in the study. The time of
rising serum sodium and hypernatre-
mia was accompanied by metabolic
alkalosis. A transient increase in total
base excess (standard base excess
from 0.1 to 5.5 mmol/L) paralleled by
a transient increase in the base excess
due to sodium (base excess sodium
from 0.7 to 4.1 mmol/L) could be
observed. The other determinants of
metabolic acid–base state remained
stable. The increase in base excess
was accompanied by a slight increase
in overall pH (from 7.392 to 7.429,
standard base excess from 0.1 to
5.5 mmol/L). Conclusions: Hyper-
natremia is accompanied by
metabolic alkalosis and an increase in
pH. Given the high prevalence of
hypernatremia, especially in critically
ill patients, hypernatremic alkalosis
should be part of the differential
diagnosis of metabolic acid–base
disorders.
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Introduction
Hypernatremia is defined as a serum sodium concentration
exceeding 145 mmol/L [1]. Usually, the development of
thirst protects us against the development of hypernatremia,
which is always associated with hyperosmolality [2]. Thus,
individuals with a disturbed sensation of thirst, unconscious
people, or those with no access to free water are prone to
develop hypernatremia [1]. Consequently, hypernatremia is
mainly a problem in persons living in nursing homes or
critically ill patients who are mechanically ventilated and
whose fluid intake is managed by the physician [3, 4].
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Despite the fact that hypernatremia was described to
be an independent predictor of mortality, only few pub-
lications can be found in the literature investigating the
effects of an increased serum sodium level on physiologic
functions [5–7]. Some older studies found that hyperna-
tremia and concurrent hyperosmolality lead to an increase
in peripheral insulin resistance or an impaired left ven-
tricular contractility [8–11]. While the physical–chemical
acid–base approach postulates that metabolic alkalosis is
a consequence of hypernatremia [12, 13], only one small
study investigated the acid–base state during hypernatre-
mia [14]. In our study we wanted to investigate the impact
of rising serum sodium levels prior to hypernatremia and
of hypernatremia per se on human acid–base state.
Methods
In this retrospective study we screened a prospectively
collected database of medical critically ill patients from a
large university hospital. From all patients with an
admission date between 1 June 2001 and 30 April 2004,
those who experienced hypernatremia for at least 1 day
were included in the study. All laboratory values includ-
ing serum sodium concentration were measured once
daily at 05:00 a.m. Hypernatremia was defined as a serum
sodium concentration exceeding 149 mmol/L [5, 15, 16].
We excluded patients who were hypernatremic on
admission to the ICU. One episode of hypernatremia was
defined by the number of consecutive days with hyper-
natremia. When patients experienced more than one
episode of hypernatremia, only the first episode was
analyzed. Maximum serum sodium concentration was
defined as the highest value within one episode. When the
highest value was measured more than once, the value
measured on the first occasion was chosen as the maxi-
mum serum sodium concentration. The last day before
and the first day after an episode of hypernatremia were
defined as the last day with normonatremia before an
episode of hypernatremia and the first day with normo-
natremia after one episode of hypernatremia, respectively.
In order to assess acid–base values while sodium rose or
decreased we also looked at the values on a day in the
middle between the last normonatremic day and the day
with maximum serum sodium concentration as well as on
a day in the middle between the day with maximum
serum sodium concentration and the first day with
normonatremia.
From all these patients we gathered data on patients’
characteristics such as age, gender, admission diagnosis,
and outcome. Additionally, all relevant acid–base data
were included in the database (pH, partial pressure of
carbon dioxide, sodium, chloride, potassium, magnesium,
ionized calcium, albumin, lactate, hemoglobin).
Acid–base analysis
Arterial blood samples were collected from the radial or
femoral artery on admission, and every day at 05:00 a.m.
The parameters used for assessment of acid–base status
were instantly measured in the same blood sample. Partial
pressure of carbon dioxide (PaCO2), pH, and ionized
calcium (Ca) were measured with a blood gas analyzer
(ABL 725, Radiometer, Copenhagen, Denmark). Sam-
ples of separated plasma were analyzed for concentrations
of sodium (Na), potassium (K), chloride (Cl), magnesium
(Mg), inorganic phosphate (Pi), and albumin by a fully
automated analyzer (Hitachi 917, Roche Diagnostics
GmbH, Mannheim, Germany). Na and Cl were measured
using ion-selective electrodes. Lactate was measured with
an amperometric electrode. Lactate was measured by the
ABL 725. All measurements were performed at 37 C
and derivative variables were calculated using constants
for 37 C. Acid–base variables are reported without cor-
rection for actual patient temperature.
HCO3
- (bicarbonate) was calculated from the mea-
sured pH and PaCO2 using the Henderson–Hasselbalch
equation [17]. Standard base excess (SBE) was calculated
according to the formula by Siggaard-Andersen [17].
Quantitative physical–chemical analysis of the results
was performed using Stewart’s quantitative biophysical
methods [13], as modified by Figge and colleagues, to
acknowledge the effects of plasma proteins [18]. The
apparent strong ion difference (SIDa) was calculated:
SIDa ¼ Na þ K þ 2  Mg2þ þ 2  Ca2þ  Cl
 lactate
(all concentrations in mmol/l).
In order to account for the role of weak acids (CO2,
albumin, and phosphate) in the balance of plasma elec-
trical charges, the effective strong ion difference (SIDe)
was calculated:
SIDe ¼ 1000  2:46  10  11
 PaCO2= 10  pHþð ÞAlb
 0:123  pH  0:631ð Þ þ Pi
 0:309  pH  0:469ð Þ
(PaCO2 in mmHg, Alb in g/L, and Pi in mmol/L).
SIDe considers the contribution of weak acids to the
electrical charge equilibrium in plasma. In the absence
of unmeasured charges the SIDa to SIDe difference
equals zero. Such charges are described by the strong ion
gap:
Strong ion gap ¼ SIDa  SIDe:
In order to compare the effects of sodium, chloride,
and albumin the base excess compounds according to
Gilfix were calculated [19] as shown below (all values in
mmol/L, if not otherwise indicated).
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Excess of free water causes hyponatremia and dilu-
tional acidosis, whereas a lack of free water causes
hypernatremia and concentrational alkalosis. Na? as the
regulated variable that controls the extracellular fluid
volume is used to assess the effect of dilution.
BE caused by free water effect BENað Þ
¼ 0:3  Naþ  NaþNormal
 
:
The constant 0.3 derives from BENa ¼ 42 
Naþ140ð Þ =140 with Naþnormal ¼ 140 mmol=L:
Hyperchloremia and hypochloremia lead to hyperch-
loremic acidosis and hypochloremic alkalosis, respectively.
The effect of changes in Cl- can be obtained by first cor-
recting Cl- for changes in free water:ClNaþcorrected ¼ Cl
Naþnormal=Na
þ ; and second :BE caused by changes in Cl-:
BECl ¼ Clnormal ClNaþcorrected:
Albumin is a weak non-volatile acid. Thus, hypoal-
buminemia is a lack of acid and results in
hypoalbuminemic alkalosis. The BE effect due to albumin
(BEAlb) can be calculated:BEAlb ¼ 0:148ð pH0:818Þ
AlbnormalAlbobservedð Þ:
The two constants in the equation account for albumin
being a weak acid, i.e., possessing variable charges
dependent on pH [18].
ABE = BENa + BECl + BEAlb + BELac + BEUMA:
Reference values were obtained from a sample of
healthy volunteers (n = 14; 8 males, 6 females; mean age
39 ± 12 years).
Statistical analysis
Data are presented as means and standard deviations, or
as median and 1st to 3rd quartiles (Q1 to Q3). Continuous
variables were compared using the Student’s t test or by
ANOVA with Tamhane’s T2 test for post hoc testing.
Proportions were compared using the v2 test. When the
expected count for cells was lower than five, Fisher’s
exact test or the exact test module by SPSS was used.
In order to study whether the components of the
metabolic acid–base state changed between observations
(last normal sodium, rising sodium, peak sodium,
declining sodium, sodium normal again) we used a gen-
eralized estimating equation. For this purpose we
assumed an exchangeable correlation matrix for repeated
observations within one patient [20]. The acid–base var-
iable (e.g., base excess) was set as the dependent variable
and the time of observation was set as the predictor using
a backward difference coding. A p value of 0.05 or less
was considered statistically significant. Statistical analysis
was performed using SPSS (SPSS for Windows release
15.0, Chicago, IL).
Results
Patient characteristics
Fifty-one patients fulfilled the inclusion criteria and
were included in the analysis. Twenty-eight patients
(55 %) were male; the mean age was 58 ± 16 years.
Length of stay was 15 (9 to 26) days (median, 1st to
3rd quartile). Thirty patients (59 %) survived to ICU
discharge. Upon ICU admission 41 patients (80 %) had
respiratory failure, 31 patients (61 %) had circulatory
failure, 17 patients (33 %) had renal failure, 8 patients
(16 %) had liver failure, and 17 patients (33 %) had
cerebral failure. None of the patients included in the
study received renal replacement therapy during their
ICU stay.
During normonatremia, central venous pressure in
patients was 14 cmH2O (Q1 10, Q3 18) and mean arterial
pressure was 79 mmHg (Q1 70, Q3 90) while central
venous pressure was 13 cmH2O (Q1 11, Q3 17) and mean
arterial pressure was 78 mmHg (Q1 69, Q3 86) during
hypernatremia. Total fluid balance during normonatremia
was ?804 mL (Q1 -141, Q3 2004) with a urine output of
2,075 mL (Q1 1,538, Q3 2,793). During hypernatremia
total fluid balance was 1,607 mL (Q1 145, Q3 2,982)
with a urine output of 1,720 mL (Q1 910, Q3 2,730).
A detailed overview on fluid balances and infusion solu-
tions administered during normo- and hypernatremia is
given in Table 1.
Table 1 Fluid balances and
administered infusion solutions
during normo- and
hypernatremia
Normonatremia Hypernatremia
Median Quartile 1 Quartile 3 Median Quartile 1 Quartile 3
Total fluid balance 804 -141 2,004 1,607 145 2,982
Total fluid input 3,684 2,510 5,329 3,179 2,427 4,298
Isotonic saline 400 100 1,200 313 100 700
Lactated Ringer’s 1,650 995 2,513 1,200 600 2,400
Distilled water 1,075 213 1,975 1,100 325 1,650
Oral input 80 23 400 135 50 470
All data in milliliters
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Electrolytes and acid–base variables
upon ICU admission
Measured immediately after admission to the ICU the
overall acid–base state of the patients was almost normal.
The acidifying effect of mildly elevated lactate and of a
mild hyperchloremic acidosis was offset by the alkalin-
zing effect of hypoalbuminemia leaving the standard base
excess normal.
Electrolytes and acid–base variables
during hypernatremia
The last day with normal serum sodium was 2 (0 to
4) days after admission to the ICU. In 37 patients a rising
serum sodium value could be recorded 1 (1–2) day after
the last day with normal serum sodium. Peak serum
sodium was recorded in all patients 3 (2–4) days after the
last day with normal serum sodium. Five (3–8) days after
the last day with normal serum sodium a declining serum
sodium value was measured in 27 patients. In 36 patients
normalization of serum sodium was recorded 5
(4–9) days after the last day with normal serum sodium.
Changes of the components of metabolic acid–base
state during hypernatremia
The development and resolution of hypernatremia was
accompanied by metabolic alkalosis. The observed tran-
sient increase in base excess was paralleled by a transient
increase in the base excess due to sodium. The other
determinants of metabolic acid–base state remained stable
(Table 2 and Fig. 1).
The increase in base excess was accompanied by a
slight increase in overall pH.
The components of overall metabolic acid–base state
(assessed by standard base excess) are shown in the fig-
ure. p values for the changes are shown in Table 3.
Discussion
In the present study of 51 critically ill patients we showed
that a rise in serum sodium during development of
hypernatremia is accompanied by an increasing pH,
Fig. 1 Course of acid–base variables prior to, during, and after
hypernatremia
Table 2 Acid–base state during the course of hypernatremia
Last normal [Na?] Rising [Na?] Peak [Na?] Declining [Na?] [Na?] normal again
Number of patients 50 37 50 27 36
pH 7.392 ± 0.104 7.421 ± 0.083 7.429 ± 0.089 7.431 ± 0.076 7.424 ± 0.089
PaCO2 (mmHg) 42.2 ± 13.8 44.3 ± 11.7 46.6 ± 12.1 45.0 ± 10.5 42.9 ± 11.6
Standard base excess 0.1 ± 4.9 3.4 ± 4.4 5.5 ± 5.6 4.7 ± 4.7 2.8 ± 4.1
HCO3
- 24.6 ± 4.8 27.8 ± 4.6 30.0 ± 5.7 29.1 ± 4.8 27.0 ± 4.2
Sodium 142 ± 3 148 ± 2 154 ± 4 149 ± 2 142 ± 3
Potassium 4.01 ± 0.69 3.79 ± 0.48 3.68 ± 0.51 3.81 ± 0.54 3.85 ± 0.57
Chloride 106 ± 5 111 ± 5 114 ± 5 110 ± 5 107 ± 5
Chloride, corrected 105 ± 4 105 ± 4 104 ± 5 104 ± 4 106 ± 5
Magnesium 0.91 ± 0.25 0.97 ± 0.24 0.95 ± 0.26 0.99 ± 0.39 0.88 ± 0.22
Ionized calcium 1.11 ± 0.09 1.12 ± 0.11 1.12 ± 0.13 1.07 ± 0.12 1.10 ± 0.11
Inorganic phosphate 1.31 ± 0.52 1.05 ± 0.44 1.00 ± 0.47 1.19 ± 0.41 1.16 ± 0.55
Lactate 2.2 ± 1.6 1.8 ± 1.1 1.8 ± 1.4 1.7 ± 1.1 1.6 ± 1.6
Albumin (g/L) 23.7 ± 5.1 22.9 ± 3.3 22.9 ± 4.1 22.1 ± 4.6 21.6 ± 4.1
Base excess sodium 0.7 ± 0.9 2.5 ± 0.6 4.1 ± 1.2 2.7 ± 0.7 0.7 ± 0.9
Base excess chloride -3.0 ± 4.5 -3.2 ± 4.3 -2.3 ± 4.5 -2.4 ± 4.5 -3.6 ± 4.6
Base excess albumin 5.8 ± 1.7 6.2 ± 0.9 6.2 ± 1.2 6.5 ± 1.3 6.6 ± 1.1
Apparent strong ion difference 40.4 ± 9.6 42.7 ± 8.8 43.2 ± 12.0 44.9 ± 5.1 38.4 ± 12.7
Effective strong ion difference 32.7 ± 8.4 36.6 ± 4.9 38.8 ± 5.6 37.9 ± 4.9 35.7 ± 4.5
Strong ion gap 7.3 ± 4.7 7.1 ± 4.5 6.7 ± 3.4 7.0 ± 5.1 5.5 ± 3.6
All variables in mmol/L unless otherwise indicated. Numbers are mean and standard deviations
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serum bicarbonate, and standard base excess defining
‘‘hypernatremic alkalosis’’.
Electrolyte disorders are an important cause of acid–
base disorders as can be derived by looking at the phys-
ical–chemical approach to acid–base disorders [12]. But
the classic approach also discusses electrolyte disorders as
potential causes of acid–base disorders [2]. However,
dyschloremia—especially hyperchloremia—as a cause of
metabolic acidosis has been the focus of a multitude
of acid–base research, primarily in critically ill patients
[21–23]. On the other hand, when searching the literature
for effects of hypernatremia on acid–base state, one will
find only few studies on this issue, despite the fact that
metabolic alkalosis is repeatedly discussed as an inde-
pendent cause of increased mortality [14, 24]. The results
presented in our study show that hypernatremic alkalosis
should be part of the differential diagnosis of metabolic
acid–base disorders.
The exact mechanisms leading to the development of
hypernatremic alkalosis are not clear; however, certain
mechanisms can be thought of: Although we do not have
detailed information on the volume state of patients
included in the present study, one can postulate that a
certain degree of free water deficit relative to absolute
sodium content as a consequence of hypertonic solution
infusion, as often seen in critically ill patients, is essential
in the development of hypernatremia [15, 25]. This in fact
would support the classic concept of contraction alkalosis
where a loss of free water leads to an absolute increase in
bicarbonate concentration and thus an increase in pH [2].
However, recently, Luke and Galla [26] reviewed con-
traction alkalosis and stated that it should be named
chloride depletion alkalosis for the following reason: it is
an increase in the sodium to chloride ratio that leads to the
development of metabolic alkalosis. Thus, diuretics, for
example, providing a loss of more chloride than sodium
lead to the development of metabolic alkalosis. Also, as
the authors mention, correction of this type of metabolic
alkalosis can only occur via the administration of chlo-
ride. From a pathophysiologic point of view a reduced
bicarbonate elimination was made responsible for the
development of metabolic alkalosis due to the relatively
low appearance of chloride in the collecting duct of the
nephron [26]. On the other hand, applying the physical–
chemical approach the development of hypernatremia is
accompanied by an increase in the subset of base excess
for sodium, explaining the development of metabolic
alkalosis.
The only previous study on the effects of hyperna-
tremia on acid–base state found that the development
of metabolic alkalosis correlated with the strong ion
difference but not with the absolute serum sodium con-
centration [14]. This finding can be explained well by use
of the physical–chemical approach: If a rise in serum
sodium is accompanied by a concurrent rise in serum
chloride concentration the effect of hypernatremia is
counteracted by the developing hyperchloremic acidosis,
resulting in no obvious change in metabolic acid–base
state as measured by base excess.
It is very easy to imagine that the mechanism men-
tioned by Luke and Galla plays a central role in our
critically ill patients: diuretics are the mainstay of therapy
in critically ill patients; additionally, in our collective,
balanced infusion solutions such as lactated Ringer’s
solution with a lower chloride content are preferred over
isotonic sodium chloride solutions, mainly in order to
avoid the development of hyperchloremic acidosis. This
administration of infusion solutions with a reduced
chloride content in addition to the administration of
diuretics may be a crucial part of the mechanisms leading
to hypernatremic alkalosis. Taken together, hypernatre-
mic alkalosis can be considered a counterpart to dilutional
acidosis.
Hypernatremia is a common event in critically ill
patients with about 2 % of patients having it on presen-
tation to the ICU and about 10 % developing it during
ICU stay [5, 6, 27]. Only recently, hypernatremia was
found to be an independent predictor of mortality in
critically ill patients [5]. In the few studies on the
mechanisms leading to ICU-acquired hypernatremia, a
strong iatrogenic component could be identified [15, 25].
Having this fact in mind, it should be clear that a
profound knowledge of the clinical implications of
(in-hospital/ICU-acquired) hypernatremia is necessary.
Nevertheless, despite the few studies which investigated
the detrimental effects of hypernatremia and the
Table 3 p values for the changes of the components of metabolic acid–base state
Change between last day
with normal serum sodium
and day with rising
serum sodium
Change between day
with rising serum
sodium and peak
serum sodium
Change between day with
peak serum sodium and
day with declining
serum sodium
Change between day with
declining serum sodium
and first day on which
serum sodium was
normal again
Lactate 0.0873 0.1000 0.2756 0.5501
Base excess sodium \0.0001 \0.0001 \0.0001 \0.0001
Base excess chloride 0.7417 0.5655 0.9879 0.2950
Base excess albumin 0.0131 0.0304 0.0541 0.0177
Strong ion gap 0.1629 0.1004 0.1042 0.0123
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associated hyperosmolality, there is a lack of modern
studies systematically studying the effects of hyperna-
tremia on physiologic functions [8–10, 28, 29]. In the
present study we were able to show that a rise in serum
sodium is associated with a rising pH and serum bicar-
bonate, indicating an alkalinizing effect of hypernatremia.
The significance of our findings for patient outcome
remains unclear so far. On the other hand, metabolic
alkalosis is the most common acid–base disturbance in
critically ill patients [30]. Presence of metabolic alkalosis
is associated with the occurrence of cardiac arrhythmias,
which are often refractory [31]. Moreover, metabolic
alkalosis leads to hypoventilation in patients with and
without lung disease [32, 33]. Finally, studies have been
published which found an increase in mortality in criti-
cally ill patients with compared to those without
metabolic alkalosis [34, 35].
Our study is limited by its retrospective design.
Additionally, we were not able to include all patients
owing to a lack of data. Although there is some evidence
that metabolic alkalosis per se has adverse effects on
patient morbidity and mortality as discussed above, the
definitive impact on a patient’s course of disease remains
uncertain.
In conclusion, the present results indicate that rising
serum sodium levels/hypernatremia lead to an increase in
pH, serum bicarbonate, and standard base excess indi-
cating metabolic alkalosis. Hypernatremic alkalosis
should considered to be an independent factor of meta-
bolic acid–base disorders comparable to hyperchloremic
acidosis and should be part of the differential diagnosis of
metabolic acid–base disturbances.
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